Navigation Links
Divine Corporation's Personal Lubricants Shown to Block Cancer-causing Viruses in a Study by the National Cancer Institute
Date:1/22/2008

An Independent Study by the National Cancer Institute Revealed Divine No. 9 and Divine No. 8 to be Highly Effective in Inhibiting Viruses that Cause

Cervical, Vaginal and Anal Cancers in vitro

ORLANDO, Fla., Jan. 22 /PRNewswire/ -- Divine Corporation announced today an unprecedented discovery in personal lubricants that promises to revolutionize the market. The National Cancer Institute's Laboratory of Cellular Oncology has completed a laboratory study of Divine Corporation's No. 9 and No. 8 personal lubricants and determined they are highly effective in blocking infection by certain strains of human papillomaviruses (HPVs) that have been proven to cause cervical, vaginal and anal cancers [1]. Divine No. 9 and Divine No. 8 personal lubricants now offer the possibility of HPV protection while at the same time enhancing the pleasure of intimate contact.

"We began by combining natural ingredients to create the best performing intimate lubricant on the market; one that would have unique and delightful play characteristics and feel great on your skin," said Stephanie Fresonke, President of Divine Corporation. "Thanks to the breakthrough work of the National Cancer Institute research team, Divine has now been shown to be an extremely potent human papillomavirus inhibitor in their laboratory studies. While clinical tests have not yet been performed, it is tremendously exciting to offer our customers the possibility to combine pleasure and protection in a single bottle."

Divine's unique formulations include an array of natural ingredients, most notably an extract from sea kelp called carrageenan. The National Cancer Institute study, "Carrageenan is a Potent Inhibitor of Papillomavirus Infection," has shown carrageenan to be an extremely effective topical microbicide for a broad range of sexually transmitted HPVs in vitro. The experiments compared a range of consumer products containing carrageenan. Divine No. 8 and Divine No. 9 proved to be the most potent virus inhibitors of any product in the study, blocking HPV infectivity even when diluted a million-fold.

[1] Buck CB, Thompson CD, Roberts JN, Muller M, Lowy DR, et al. (2006) Carrageenan Is a Potent Inhibitor of Papillomavirus Infection. PLoS Pathog 2(7): e69 doi:10.1371/journal.ppat.0020069

About Divine Corporation

Divine Corporation is dedicated to making intimate situations as safe and enjoyable as they possibly can be. Intensive research has led to a line of products formulated with natural ingredients that are shown to block life- altering viruses in independent laboratory studies. In addition, both unscented Divine No. 9 and vanilla-scented Divine No. 8 are known for their exotic, slippery feel that dries clean, never sticky. Look for Divine personal lubricants in health food stores, on-line drugstores such as Drugstore.com, and other discriminating websites. Learn more at http://www.divinetimes.com.

FOR FURTHER INFORMATION, PLEASE CONTACT:

Debbie Gallaher, +1.407.468.4228, debbie@divinetimes.com


'/>"/>
SOURCE Divine Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
2. Personalized Medicine - The Genomic Revolution in Cardiac Care
3. SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients
4. RediClinic Offers Affordable New Plan Clinically Shown to Double a Persons Chance to Stop Smoking
5. Study Confirms That New Protocol Shortens the Time It Takes to Open Blocked Arteries for Heart Attack Patients
6. Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
7. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
8. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
9. Northwestern Memorial Transplant Program Initiates New Study
10. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
11. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Calif. , June 24, 2016  American Respiratory Labs (ARL), ... is now able to perform sophisticated lung assessments in patients, homes, ... , Inc. Patients are no longer limited to ... EasyOne PRO ® , ARL patients like Jeanne R. of ... in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
Breaking Medicine Technology:
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
Breaking Medicine News(10 mins):